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specific force and provides the first independent replication, 
in a larger Caucasian cohort, of an association between 
these PTK2 SNPs and muscle specific force, thus extending 
our understanding of the influence of genetic variation on 
the intrinsic strength of muscle.
Keywords Protein tyrosine kinase 2 · Vastus lateralis · 
Lateral transmission · Focal adhesion kinase · Muscle 
quality · Genetic polymorphism
Abbreviations
ACSA  Anatomical cross-sectional area
ANCOVA  Analysis of covariance
ANOVA  Analysis of variance
AVI  Audio video interleave
BMI  Body mass index
CcT  Co-activation torque
DXA  Dual energy X-ray absorptiometry
ECM  Extracellular matrix
EMG  Electromyography
FAK  Focal adhesion kinase
MVCKE  Maximal voluntary isometric knee extension
MVCKF  Maximal voluntary isometric knee flexion
PCSA  Physiological cross-sectional area
PTK2  Protein tyrosine kinase 2
SNP  Single nucleotide polymorphism
STT  Superimposed twitch torque
Introduction
Muscle specific force, defined here as the force per unit 
cross-sectional area of muscle, represents the intrinsic 
strength of a muscle and is a key determinant of func-
tional capacity and mobility in later life which should be 
Abstract 
Purpose The aim of the study was to investigate two sin-
gle nucleotide polymorphisms (SNP) in PTK2 for associa-
tions with human muscle strength phenotypes in healthy 
men.
Methods Measurement of maximal isometric vol-
untary knee extension  (MVCKE) torque, net  MVCKE 
torque and vastus lateralis (VL) specific force, using 
established techniques, was completed on 120 Cauca-
sian men (age = 20.6 ± 2.3  year; height = 1.79 ± 0.06  m; 
mass = 75.0 ± 10.0  kg; mean ± SD). All participants pro-
vided either a blood (n = 96) or buccal cell sample, from 
which DNA was isolated and genotyped for the PTK2 
rs7843014 A/C and rs7460 A/T SNPs using real-time poly-
merase chain reaction.
Results Genotype frequencies for both SNPs were in 
Hardy–Weinberg equilibrium (X2 ≤ 1.661, P ≥ 0.436). VL 
specific force was 8.3% higher in rs7843014 AA homozy-
gotes than C-allele carriers (P = 0.017) and 5.4% higher in 
rs7460 AA homozygotes than T-allele carriers (P = 0.029). 
No associations between either SNP and net  MVCKE 
torque (P ≥ 0.094) or peak  MVCKE torque (P ≥ 0.107) were 
observed.
Conclusions These findings identify a genetic contri-
bution to the inter-individual variability within muscle 
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maintained (McGregor et  al. 2014). In young, untrained 
adults muscle specific force varies inter-individually 
by 14–16% (Stebbings et  al. 2014; Erskine et  al. 2009), 
which might suggest some individuals are predisposed 
to possessing greater muscle specific force and may, 
therefore, be less susceptible to experiencing functional 
declines associated with ageing. Whilst it is generally 
accepted that differences in the force generating capacity 
of individual fibres (Bottinelli et  al. 1996), intramuscu-
lar fat and/or connective tissue content (Macaluso et  al. 
2002; Kent-Braun et  al. 2000) contribute to this inter-
individual variability, it is possible that genetic differ-
ences also contribute. Accordingly, two single nucleotide 
polymorphisms (SNPs) of the protein tyrosine kinase 2 
gene (PTK2), responsible for encoding focal adhesion 
kinase (FAK), were found to explain ~10% of the inter-
individual variability in the muscle specific force of 
untrained individuals (Erskine et al. 2012).
Focal adhesion kinase is an integrin-associated protein 
tyrosine kinase localised at focal adhesion complexes via 
interactions between its focal adhesion targeting domain 
and other integrin-associated proteins (Hildebrand et  al. 
1993; Schaller 2001). Focal adhesion complexes are 
important components of cell costameres, which overlie 
the Z- and M-lines of myofibres and form regular con-
nections with the sarcolemma (Pardo et al. 1983). Thus, 
a pathway of force transmission exists by which force can 
be transmitted laterally across adjacent myofibres and 
the sarcolemma to the extracellular matrix (ECM) (Flück 
et al. 1999; Patel and Lieber 1997; Bloch and Gonzalez-
Serratos 2003), via these regular connections. Given the 
location of costameres, they could effectively split the 
serial sarcomeres of a myofibre into multiple force-gen-
erating units to enable this pathway of force transmission 
to the muscle fascia, although this hypothesis is specu-
lative (Jones et  al. 1989; Huijing 1999). Costamere for-
mation and turnover is regulated by FAK activity, which 
is known to increase in hypertrophying muscle (Flück 
et al. 1999). Similarly, increases in muscle specific force 
are also observed following skeletal muscle hypertrophy 
(Reeves et al. 2004b), which is thought to be the conse-
quence of an increased costamere density (Erskine et al. 
2012). A greater costamere density, that is an increase 
in the number of intermediate connections between 
the ECM, myofibre and aponeurosis, may result in an 
increase in the number of force-generating units within a 
fibre, and thus, whole muscle, without the need for addi-
tional parallel sarcomeres. Consequently, the force gen-
erated by the muscle fibre and whole muscle would be 
greater despite physiological cross-sectional area (PSCA) 
remaining constant, thus enhancing muscle specific force. 
Indeed where alterations to normal costamere function 
have been observed in dystrophic muscle, decreased 
specific force was attributed to an inferior ability to trans-
mit force laterally due to deficiencies in important costa-
meric proteins (Ramaswamy et al. 2011).
The PTK2 rs7843014 and rs7460 polymorphisms, which 
are in linkage disequilibrium (Erskine et  al. 2012), were 
recently associated with the level of gene expression and 
exceptional longevity in a Spanish population (Garata-
chea et al. 2014). More specifically, the rs7843014 CC and 
rs7460 TT genotypes were tentatively associated with lower 
PTK2 gene expression whilst being optimal for exceptional 
longevity (Garatachea et  al. 2014). In a population of 
healthy Caucasian men, however, it was the rs7843014 AA 
and rs7460 AA genotypes that were significantly associated 
with producing higher baseline specific force (Erskine et al. 
2012). The authors speculated that the rs7843014 AA and 
rs7460 AA homozygotes had improved lateral force trans-
mission due to an increased costamere density compared 
to C-allele and T-allele carriers, respectively (Erskine et al. 
2012). This preliminary report, however, involved only a 
small population (n = 51), therefore, independent replica-
tions are required to confirm these initial observations.
The aim of the current investigation, therefore, was to 
investigate if the rs7843014 and rs7460 polymorphisms 
within the PTK2 gene were associated with skeletal mus-
cle specific force and other measures of muscle strength in 
a larger population of Caucasian men, independent of that 
done previously. We hypothesized that the rs7843014 AA 
and rs7460 AA genotypes would be significantly associated 
with higher specific force, maximal isometric voluntary 
knee extension  (MVCKE) torque and net  MVCKE torque 
production than C-allele and T-allele carriers, respectively.
Methods
Participants
Participants were healthy, unrelated Caucasian men 
(n = 120, Table 1) who had not undertaken any structured 
training in the preceding 12 months and had not taken part 
in the aforementioned preliminary report (Erskine et  al. 
2012). Participants were free from musculoskeletal or neu-
rological disorders, had a body mass index (BMI) between 
18.5 and 30.0 kg m−2 and all gave written consent to par-
ticipate. Habitual physical activity levels were assessed 
via questionnaire (Baecke et al. 1982) to ensure only those 
participants who undertook less than 3 h of low-to-moder-
ate habitual work-based and leisure-time physical activity 
per week were included in the study. The Ethics commit-
tee of Manchester Metropolitan University granted ethical 
approval and all experimental procedures complied with 
the Declaration of Helsinki.
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Knee extension and flexion torque
Maximal voluntary isometric knee flexion  (MVCKF) torque 
and  MVCKE was assessed using an isokinetic dynamometer 
(Cybex Norm, Cybex International Inc., NY, USA) whilst 
participants were seated at 85° hip flexion and secured with 
straps across the shoulders, waist and right thigh. Partici-
pants completed a minimum of three  MVCKE and  MVCKF 
contractions at knee joint angles of 70°, 80° and 90° of 
knee flexion on the right leg in a randomised order, with 
2  min rest between contractions. The knee joint angle at 
which peak  MVCKE torque occurred was considered the 
optimal angle and was used for subsequent measurements 
of net  MVCKE and specific force. The right limb of each 
participant was selected for assessment as previous inves-
tigations using untrained participants have reported no sig-
nificant bilateral differences in MVC torque (Lindle et  al. 
1997; Hageman et al. 1988; Häkkinen et al. 1998), in addi-
tion to determinants of this, such as muscle architecture 
(Kearns et al. 2001), size and EMG (Häkkinen et al. 1996).
Muscle activation and co‑activation
Two self-adhesive electrodes (7.5 × 12.5 cm; Tyco Galvanic 
Pad, Uni-Patch, MN, USA) were positioned over the muscle 
belly of the vastus medialis, rectus femoris and vastus later-
alis and connected to an external stimulation device (DS7, 
Digitimer stimulator, Welwyn, Garden City, UK) such that 
the anode was placed 5–10  cm proximal to the superior 
border of the patella and the cathode was located 5–10 cm 
distal to the inguinal crease (Place et  al. 2010). With the 
participant at rest, the maximal twitch torque stimulation 
intensity was identified by administering single twitches 
of increasing current intensity until no further increases 
in twitch torque were observed. The current intensity at 
which no further increases in twitch torque were observed 
was defined as the supramaximal stimulation intensity and 
this intensity was superimposed during  MVCKE to allow 
for the calculation of net  MVCKE torque, together with co-
activation torque. Antagonist muscle co-activation during 
 MVCKE was determined through electromyographic (EMG) 
assessment of the biceps femoris. Two pre-gelled Ag–AgCl 
electrodes (Ambu, Neuroline 720, Denmark) were posi-
tioned in the mid-sagittal plane over the distal third of the 
long head of the biceps femoris, with an inter-electrode dis-
tance of 20 mm, and a reference electrode was positioned 
over the lateral tibial condyle. The integral of the root mean 
square EMG activity corresponding to peak  MVCKE torque 
at the optimal knee joint angle was calculated and averaged 
over 0.5 s either side of the instantaneous peak. EMG activ-
ity of the biceps femoris during  MVCKF was measured and, 
assuming a linear relationship between torque and EMG 
activity, was used to estimate co-activation torque (Reeves 
et al. 2004b). Subsequently, net  MVCKE torque was calcu-
lated as CcT + (MVCKE + STT), where CcT is the co-acti-
vation torque and STT is the superimposed twitch torque 
obtained using the interpolated twitch technique.
Muscle architecture
Vastus lateralis (VL) muscle architecture was assessed 
in vivo at 50% of muscle length using B-mode ultrasonog-
raphy (AU5, Esaote, Italy) during  MVCKE at the predeter-
mined optimum joint angle. The 40 mm, 7.5 MHz linear-
array probe was placed perpendicular to the skin over an 
echo-absorptive reference marker in the mid-sagittal plane 
during image acquisition. Ultrasound scans were recorded 
at a sampling frequency of 25 Hz in audio video interleave 
(AVI) format and all signals of torque, electrical stimuli 
and EMG activity were displayed on a computer screen, 
interfaced with an acquisition system (AcqKnowledge, 
Biopac Systems, Santa Barbara, USA), to enable analogue-
to-digital conversion at a sampling frequency of 2000 Hz. 
Single images were captured for measurement of pennation 
angle and fascicle length on a minimum of three fascicles 
from which the mean was recorded (NIH ImageJ, version 
1.44o, National Institute of Health, Bethesda, Maryland). 
Measurement of fascicle length in all instances required 
extrapolation of the superficial and deep aponeuroses to 
allow for estimation of fascicle length, due to fascicles 
extending beyond the ultrasound field of view (Reeves and 
Narici 2003).
Table 1  Participant physical characteristics according to PTK2 genotype frequency for the rs7843014 and rs7460 polymorphisms
Frequency data presented as count (%), all other data presented as mean ± SD
All rs7843014 P rs7460 P
AA AC CC AA AT TT
Frequency (%) 120 (100) 42 (35) 52 (43) 26 (22) 34 (28) 54 (45) 32 (27)
Age (years) 20.6 ± 2.3 20.4 ± 2.7 20.7 ± 2.3 20.8 ± 2.4 0.705 20.4 ± 2.3 20.8 ± 2.4 20.4 ± 2.2 0.623
Height (m) 1.79 ± 0.06 1.78 ± 0.06 1.79 ± 0.07 1.79 ± 0.06 0.594 1.79 ± 0.07 1.80 ± 0.05 1.77 ± 0.07 0.217
Mass (kg) 75.0 ± 10.0 72.9 ± 9.3 75.4 ± 10.4 77.4 ± 10.0 0.180 74.9 ± 11.0 76.8 ± 9.3 72.0 ± 9.7 0.106
BMI (kg m−2) 23.4 ± 2.7 23.0 ± 2.5 23.4 ± 2.7 24.1 ± 3.1 0.248 23.5 ± 3.0 23.7 ± 2.7 22.8 ± 2.5 0.326
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Tendon moment arm length
Patellar tendon moment arm length was measured using 
a single, low-energy (0.9  μSv) sagittal plane dual energy 
X-ray absorptiometry (DXA) scan (22.6 × 13.7  cm; Hol-
ogic Discovery W, Vertec Scientific Ltd, UK) (Erskine 
et al. 2014). During scanning, each participant lay on their 
side with the hip flexed at 85° and the right knee joint posi-
tioned at the previously determined optimum angle using 
a goniometer. Scans were exported (OsiriX 5.0.2, Pixmeo 
Sarl, Geneva, Switzerland) and the perpendicular dis-
tance between the tibiofemoral contact point and the axis 
of the patellar tendon was measured as the patellar tendon 
moment arm length (Tsaopoulos et al. 2006). Patellar ten-
don force was calculated by dividing net  MVCKE torque by 
patellar tendon moment arm length. The contribution of the 
VL to patellar tendon force was estimated using previously 
reported data (Narici et al. 1992), and divided by the cosine 
of pennation angle to estimate VL fascicle force.
VL muscle size and specific force
Transverse ultrasound scans were obtained from the medial 
to lateral muscle border at 50% of VL muscle length and 
recorded in AVI format to assess VL anatomical cross-
sectional area (ACSA) (Reeves et al. 2004a). Single scans 
were contour matched to provide a complete image of VL 
ACSA, which was measured using digitizing software. 
Muscle volume was estimated using ACSA, VL muscle 
length and a series of regression-derived constants, as vali-
dated previously (Morse et  al. 2007). Calculation of VL 
muscle PCSA was achieved by dividing VL muscle volume 
by fascicle length. Ultimately, VL specific force was calcu-
lated by dividing VL fascicle force by VL PCSA (Reeves 
et al. 2004b).
Blood sampling, DNA isolation and genotyping
A 5  mL blood sample was collected from a superficial 
forearm vein of 96 participants into EDTA tubes (BD 
Vacutainer Systems, Plymouth, UK) and stored at −20 °C 
in 2 mL microcentrifuge tubes (Eppendorf AG, Hamburg, 
Germany). For 24 participants, buccal cell samples were 
obtained in duplicate (Whatman Sterile OmniSwab, GE 
Healthcare, USA) following a minimum 1-h abstinence 
from food and drink, according to the manufacturer’s 
guidelines. Each collection tip was ejected into a 2 mL 
microcentrifuge tube and stored at −20 °C.
The Qiagen QIAcube spin protocol (Qiagen, Crawley, 
UK) was completed in accordance with the manufacturer’s 
guidelines using the buffers contained in the Qiagen DNA 
Blood Mini kit for the extraction of genomic DNA from 
whole blood and buccal samples. Genotyping of PTK2 
rs7843014 and rs7460 was carried out using real-time 
PCR in 96-well plates each containing a reaction volume 
of 10  μL. For DNA obtained from whole blood samples, 
the reaction volume contained 0.2 μL of participant DNA 
(9.9 ± 1.1  ng, amounts determined using ~20% of partici-
pant DNA samples), 5  μL of TaqMan genotyping master 
mix (Applied  Biosystems®, UK), 4.3  μL of nuclease-free 
 H2O and 0.5  μL of TaqMan genotyping assay mix. For 
DNA samples obtained from buccal cells, the 10 μL reac-
tion volume contained 1 μL of participant DNA (18.6 ± 4.6 
ng), 5  μL of TaqMan genotyping master mix, 3.5  μL of 
nuclease-free  H2O and 0.5 μL of TaqMan genotyping assay 
mix. In control wells, nuclease-free  H2O replaced the DNA 
sample.
The PCR plate was sealed (Microseal ‘B’ adhesive seal, 
Bio-Rad Laboratories, Hercules, CA) and DNA amplifica-
tion (Chromo4 Real-Time PCR Detection System, Bio-Rad 
Laboratories) of each polymorphism was completed using 
the following PCR protocol: 10 min at 95 °C followed by 
40 cycles of denaturation for 15 s at 92 °C, primer anneal-
ing and extension for 1 min at 60 °C and plate read. Geno-
types were determined by measurement of end-point fluo-
rescence of  VIC® and  FAM® detected by the PCR machine 
and analysed using Opticon Monitor software (Bio-Rad 
Laboratories). For the rs7460 polymorphism the alleles 
indicated by  VIC® and  FAM® were converted and nucleo-
tides were reported according to NCBI (http://www.ncbi.
nlm.nih.gov/snp/?term=rs7460). All samples were ana-
lysed in duplicate and 100% agreement between all dupli-
cate samples was achieved.
Statistical analysis
The frequency of each polymorphism was assessed for 
compliance with Hardy–Weinberg equilibrium using χ2 
tests. A one-way analysis of variance (ANOVA) was con-
ducted to determine any significant differences in physical 
characteristics (height, mass, BMI and age) between geno-
types. Pearson’s correlations were used to identify variables 
that made a meaningful contribution to the variability of the 
muscle phenotype under investigation, and those identified 
were included as confounding variables in subsequent anal-
yses of covariance (ANCOVA). ANOVA, or where appro-
priate ANCOVA, was conducted to investigate genotype 
differences in muscle strength phenotypes and linear trend 
analyses were used to assess genotype associations with 
muscle strength phenotypes. Post-hoc pairwise compari-
sons were subjected to Benjamini–Hochberg corrections. 
Where a tendency between genotype groups was observed 
(P between 0.05 and 0.10), the two genotype groups with 
most similar means were combined and compared using an 
independent samples t test (Erskine et  al. 2012). Further-
more, the extent of linkage disequilibrium between PTK2 
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rs7843014 and rs7460 was determined using CubeX online 
software (http://www.oege.org/software/cubex) to estimate 
haplotype frequencies and calculate D′ and R2 as the dif-
ference between the observed and expected haplotype fre-
quencies (Gaunt et al. 2007). Statistical analyses were per-
formed using SPSS version 19.0 and alpha set at 0.05. Data 
are presented as mean ± SD.
Results
Genotype frequencies for PTK2 rs7843014 (AA = 35.0%, 
AC = 43.3%, CC = 21.7%) and rs7460 (AA = 28.3%, 
AT = 45.0%, TT = 26.7%) were in Hardy–Weinberg equi-
librium (χ2 ≤ 1.661, P ≥ 0.436). There were no differences 
between genotypes of either SNP for height, mass, BMI 
or age (P ≥ 0.106; Table 1). There were moderate correla-
tions between muscle volume (r ≥ 0.361, P ≤ 4.7 × 10−4), 
PCSA (r ≥ 0.417, P ≤ 2.2 × 10−6) and all muscle strength 
phenotypes. Consequently, muscle volume was included as 
a covariate in analyses of  MVCKE torque and net  MVCKE 
torque but not specific force, as this is accounted for during 
the calculation of muscle specific force.
VL specific force tended to differ between geno-
type groups for PTK2 rs7843014 (P = 0.060) and rs7460 
(P = 0.089; Table  2). VL specific force of rs7843014 AA 
homozygotes was 8.3% higher than C-allele carriers 
(P = 0.017; Fig.  1). Similarly, rs7460 AA homozygotes 
had 5.4% higher VL specific force than T-allele carriers 
(P = 0.029; Fig.  1). Linkage disequilibrium between the 
two SNPs was calculated as D′ = 0.894 and R2 = 0.591. 
Thus, while individual contributions of rs7843014 and 
rs7460 to inter-individual variability in VL specific force 
were 3.5% (P = 0.041) and 3.3% (P = 0.048), respectively, 
no more variability (3.8%, P = 0.107) could be accounted 
for by both SNPs together.
Net  MVCKE torque tended to differ between rs7843014 
genotype groups (P = 0.094; Table  2), although there was 
no difference between AA homozygotes and C-allele car-
riers (P = 0.128). However, there was a linear trend in net 
 MVCKE torque of AA > AC > CC (P = 0.041, ηp2 = 0.042). 
No differences in net  MVCKE torque were observed 
between genotype groups for PTK2 rs7460 (P = 0.275), nor 
were there any genotype differences in  MVCKE torque for 
either polymorphism (P ≥ 0.107; Table  2). Similarly, no 
differences in any architectural or size phenotypes were 
observed between genotype groups for either polymor-
phism (P ≥ 0.133; Table 2).
Discussion
The aim of this study was to investigate the relationship 
between polymorphisms in the PTK2 gene and muscle 
Table 2  Muscle strength characteristics according to PTK2 rs7843014 and rs7460 genotype
P denotes genotype group differences
VL vastus lateralis, ACSA anatomical cross-sectional area, PCSA physiological cross-sectional area, MVCKE maximal voluntary knee extension
rs7843014 P rs7460 P
AA AC CC AA AT TT
VL fascicle length (cm) 7.2 ± 1.8 7.0 ± 1.4 7.5 ± 1.4 0.371 7.3 ± 1.4 7.1 ± 1.7 7.2 ± 1.7 0.844
VL pennation angle (°) 19.2 ± 3.8 20.1 ± 4.0 18.5 ± 3.6 0.183 18.8 ± 3.1 20.2 ± 4.6 18.8 ± 3.0 0.133
VL ACSA  (cm2) 21.0 ± 2.4 21.6 ± 2.7 21.9 ± 2.2 0.351 21.6 ± 2.3 21.5 ± 2.6 21.1 ± 2.7 0.689
VL PCSA  (cm2) 71.3 ± 10.9 71.6 ± 13.6 72.7 ± 13.8 0.912 70.4 ± 15.0 72.3 ± 11.5 72.2 ± 12.3 0.768
Peak  MVCKE torque (N m) 260 ± 50.9 250 ± 43.0 243 ± 44.7 0.107 253 ± 51.7 250 ± 42.0 243 ± 45.9 0.495
Net  MVCKE torque (N m) 286 ± 53.0 272 ± 56.1 257 ± 46.2 0.094 276 ± 57.8 267 ± 53.8 259 ± 46.9 0.275
VL specific force (N cm−2) 22.3 ± 2.6 21.1 ± 2.6 21.1 ± 2.6 0.060 22.4 ± 2.8 21.3 ± 2.5 21.1 ± 2.6 0.089
Fig. 1  Vastus lateralis specific force according to PTK2 rs7843014 
and rs7460 genotype. rs7460 AA homozygotes (black bars) had 
higher specific force than T-allele carriers (white bars; *P = 0.029) 
and rs7843014 AA homozygotes (black bars) had higher spe-
cific force than C-allele carriers (white bars; ‡P = 0.017). Data are 
mean ± SD
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strength phenotypes in a healthy population. Genotype 
and allele frequencies for PTK2 rs7843014 and rs7460 
were similar to previous reports in Caucasian popula-
tions (Erskine et al. 2012), while mean  MVCKE torque, net 
 MVCKE torque and VL specific force in the current study 
(250 N m, 274 N m and 21.4 N cm−2, respectively) were 
in accordance with previous reports in comparable popu-
lations (Narici et al. 1992; Erskine et al. 2012, 2009). We 
report a genotype–phenotype association between each of 
the PTK2 SNPs and VL specific force.
PTK2 is the gene encoding FAK, a protein integral to 
the formation and turnover of muscle costameres (Quach 
and Rando 2006). During muscle contraction, muscle cos-
tamere complexes are involved in transmitting force lat-
erally from the muscle contractile elements to the ECM 
(Bloch and Gonzalez-Serratos 2003). Differing ability of 
muscle to transmit force laterally may translate into varia-
bility in maximal joint torque and/or muscle specific force. 
In the current study, polymorphisms in the PTK2 gene were 
associated with VL specific force but not  MVCKE torque, 
net  MVCKE torque, muscle architecture or size. Individu-
als homozygous for the rs7843014 A-allele had greater VL 
specific force than their C-allele counterparts (8.3%), and 
those homozygous for the rs7460 A-allele demonstrated 
greater VL specific force than T-allele carriers (5.4%; 
Fig. 1). When considering a previous study observed no dif-
ferences in quadriceps femoris specific force between men, 
women, boys or girls (O’Brien et al. 2010) these genotype-
group observations represent important differences. Fur-
thermore, the inter-individual variability observed within 
this phenotype was 16%, and together, the two PTK2 SNPs 
explain a substantial proportion (~25%) of this variability. 
A previous report on the influence of PTK2 rs7843014 and 
rs7460 on muscle strength also reported a significant asso-
ciation between quadriceps femoris muscle specific force 
and A-allele (rs7843014 and rs7460) homozygotes in a 
smaller Caucasian cohort (Erskine et  al. 2012). Thus, the 
current investigation provides the first independent replica-
tion of the findings from this previous smaller cohort study 
and together these findings demonstrate a probable associa-
tion of PTK2 with muscle specific force.
A plausible explanation for the findings of the current 
investigation may be that AA (rs7843014 and rs7460) 
homozygotes experience altered PTK2 expression com-
pared to their C-allele (rs7843014) and T-allele (rs7460) 
carrying counterparts. Interestingly, an association between 
CC (rs7843014) and TT (rs7460) genotypes and lower gene 
expression in Spanish Caucasians has been reported (Gara-
tachea et  al. 2014). Furthermore, in vitro FAK-null cells 
demonstrate diminished integrin activation and a reduced 
adhesion-strengthening rate, which results in the formation 
of fewer integrin-ECM bonds, compared to cells express-
ing FAK (Michael et  al. 2009). Contrastingly, however, 
evidence exists reporting FAK-null cells actually form 
stronger adhesions, possess enhanced contractile proper-
ties and migrate slower than their wild-type counterparts 
(Ilic et  al. 1995; Chen et  al. 2002; Ren et  al. 2000), thus 
demonstrating the complexity surrounding FAK-regulated 
adhesion strength and the role of PTK2 in the variation 
within muscle specific force production. Both rs7843014 
and rs7460 are in non-coding regions, and although it is 
unlikely that either the SNP would result in changes to the 
amino acid sequence of FAK that would elicit comparable 
effects to those of FAK-null cells, potential alterations to 
the magnitude, location and timing of gene expression, or 
mRNA stability as a consequence of one or both of these 
SNPs cannot be discounted (Laguette et al. 2011; Septem-
ber et al. 2009).
The observed association between the AA genotypes 
and enhanced VL specific force might be attributable to 
an increased costamere density as a consequence of more 
integrin-ECM bonds with higher gene expression (Bang 
et  al. 2001), compared to T-allele (rs7460) and C-allele 
(rs7843014) carriers (Garatachea et al. 2014). Although it 
remains unclear how an increased costamere density corre-
sponds to an increase in specific force, it could be achieved 
via enhanced lateral transmission of force (Jones et al. 1989; 
Street 1983). An increased costamere density is likely to 
result in more intermediate connections between the ECM, 
myofibres and aponeurosis, effectively splitting serial sar-
comeres into numerous force-generating units whilst also 
reducing functional muscle fibre length (Jones et al. 1989). 
Assuming all else is equal, it is hypothesized that more 
force-generating units within a fibre would reduce maximal 
shortening velocity whilst enabling a simultaneous increase 
in force generation within a given PCSA, thus resulting in 
increased muscle specific force (Jones et al. 1989; Huijing 
1999). Whilst evidence to support this hypothesis is tenu-
ous, Erskine et al. (2011) observed an increase in specific 
force but not power per unit of muscle mass following 
resistance training. Given that maximal muscle power is the 
product of maximal shortening velocity, which is expected 
to reduce with an increased costamere density, and maxi-
mal force, which is expected to increase with an increased 
costamere density, when power is normalized to muscle 
volume it should remain unchanged despite an increase in 
specific force as a consequence of an increased costamere 
density. As Erskine et al. (2011) did not determine maximal 
shortening velocity, it is unclear if their observed increase 
in specific force was inversely proportional to maximal 
shortening velocity and would explain why normalized 
power remained unchanged. Future research is, therefore, 
necessary to include measurements of maximal shortening 
velocity alongside specific force and power, to confirm or 
refute this speculation. Although the mechanism by which 
costamere density might contribute to enhanced lateral 
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force transmission is currently undetermined, proposed 
mechanisms include the presence of a greater number of 
costameres per muscle fibre and/or a greater number of 
smaller fibres per muscle and thus a higher fibre perimeter-
to-area ratio (Erskine et  al. 2012). If the latter were true, 
a muscle containing a greater number of smaller fibres 
could exhibit comparable muscle size and architecture to 
a muscle containing fewer larger fibres. Accordingly, the 
data presented in Table 2 revealed no associations between 
PTK2 genotype and any muscle architectural or size phe-
notypes, thus suggesting a greater number of smaller fibres 
may contribute to an increased costamere density. Future 
research should investigate PTK2 genotype differences in 
muscle costamere density via direct measurement to con-
firm or refute this hypothesis.
Further to specific force, we hypothesized that PTK2 
genotype would be associated with  MVCKE and net  MVCKE 
torque, but no associations were observed. It is possible 
that any genotype associations with these phenotypes were 
masked by inter-individual variability in other important 
determinants of torque, such as muscle size, architecture, 
activation capacity, co-activation and tendon moment arm 
length (Stebbings et  al. 2014). Indeed the inter-individual 
variability observed in these determinants within the cur-
rent study ranged from 6% for muscle activation and co-
activation capacity to ~20% for muscle architecture and 
size.
Conclusion
This study has identified an association between poly-
morphisms in the PTK2 gene and VL muscle specific 
force, thus providing an independent replication of previ-
ous research conducted on the quadriceps femoris mus-
cle group (Erskine et al. 2012). These findings extend our 
understanding of the influence of genetic variation on the 
intrinsic strength of a muscle and have potential implica-
tions for ageing populations for whom the maintenance of 
muscle specific force is important to promote independence 
and a better quality of life.
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